Carole A. Heilman, Ph.D., was recently named director of the Division of
Microbiology and Infectious Diseases (DMID) of the National Institute of
Allergy and Infectious Diseases (NIAID). She comes to this position from
NIAID's Division of AIDS, where she served as deputy director for the past
"Dr. Heilman brings considerable experience and expertise to her new
position," says Anthony S. Fauci, M.D., director of NIAID. "I am confident
that she will bring her imaginative and creative leadership to address the
future challenges in infectious disease research."
Dr. Heilman began her career at NIH in 1978 as a postdoctoral research
associate with the National Cancer Institute where she carried out research
on the regulation of gene expression during cancer development. In 1986,
she came to NIAID as the influenza and viral respiratory diseases program
officer in DMID and, in 1988, she was appointed chief of the respiratory
diseases branch where she coordinated the development of acellular pertussis
She joined the Division of AIDS as deputy director in 1997 and was
responsible for developing the Innovation Grant Program for Approaches in
HIV Vaccine Research. This program was created to encourage novel ideas and
approaches in HIV vaccine research while stimulating interest from a new
group of scientists, including those who had not been involved in HIV
research. The program was designed to speed the pace of discovery and
development of vaccines to prevent HIV infection.
As a member of the HIV Vaccine Innovation Grants Team, Dr. Heilman received
the 1998 NIH Director's Award "for exceptional initiative, creativity and
sustained productivity required for creation and implementation of the HIV
Vaccine Innovation Grants Program." Most recently, she received the
Secretary's Award for Distinguished Service for "exceptional leadership of
the global efforts to identify a safe and effective vaccine to prevent
AIDS." She also received the 1992 NIH Director's Award and the 1990 NIH
Merit Award for her efforts in developing and implementing Cooperative
Research and Development Agreements (CRADAs), collaborations between NIAID
scientists and industry to enhance product development for improving public
Dr. Heilman received her bachelor's degree in biology from Boston University
in 1972, and earned her master's degree and doctorate in microbiology from
Rutgers University in 1976 and 1979, respectively.
Throughout her extramural career, Dr. Heilman has contributed articles on
vaccine design and development to many scientific journals and has served as
consultant to the World Bank and the World Health Organization in this area.
She is also a member of several professional societies, including the
Infectious Diseases Society of America; the American Society for
Microbiology; and the American Society for Virology.
NIAID is a component of the National Institutes of Health (NIH). NIAID
conducts and supports research to prevent, diagnose and treat illnesses such
as HIV disease and other sexually transmitted diseases, tuberculosis,
malaria, asthma and allergies. NIH is an agency of the U.S. Department of
Health and Human Services.
Press releases, fact sheets and other NIAID-related materials are available
on the NIAID Web site at http://www.niaid.nih.gov.